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In a small percentage of patients with systemic lupus erythematosus (SLE), ~ an 
autoantibody that is reactive with a nuclear antigen in proliferating cells (PCNA) 
has been demonstrated (1).  Using this autoantibody as the reagent in immuno- 
fluorescence, PCNA  was not detected in  differentiated, nondividing cells such 
as renal tubular or giomerular cells nor in hepatic parenchymal cells. However, 
continuous  tissue  culture  cell  lines  of different species  such as  WiL-2,  Hep-2, 
baby  hamster  kidney  cells,  and  Ehrlich  ascites  tumor  cells  were  positive  for 
PCNA.  Normal  peripheral  blood  lymphocytes  did  not  contain  detectable 
amounts  of  PCNA,  but  it  was  present  in  some  lymphocytes  in  lymph  node 
follicles,  spleen,  and  thymus.  After  mitogenic  stimulation,  peripheral  blood 
lymphocytes became positive for PCNA, demonstrable as nuclear staining in the 
blast-transformed cells. 
The reactive nuclear antigen was extractable from tissue culture cells or rabbit 
thymus with physiological saline. Solubilized PCNA formed a precipitin line with 
autoantibody that was immunologically distinct from previously identified anti- 
gen-autoantibody systems such as Sm antigen,  nuclear RNP,  SS-A/Ro, and SS- 
B/La (2). 
The incidence of anti-PCNA antibody is <5% in SLE patients and it does not 
appear to be associated with any distinctive clinical characteristics in such patients 
(1).  However, because of the apparent association of PCNA  with proliferation 
and  blast  transformation,  it  has  been  used  as  a  probe  to detect  blast  crisis  in 
patients with leukemia. 2 In this report we describe methods for purification of 
PCNA and some of the biochemical characteristics of the antigen. 
Methods 
Preparation  of Specific  Anti-PCNA  Serum.  Three anti-PCNA  sera (MN,  EB, and  PT) 
obtained  from  patients  with  SLE  were  used.  In  addition  to  anti-PCNA,  these  sera 
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contained autoantibodies to other nuclear antigens including double-strand DNA, histone, 
Sm,  and  SS-A/Ro (see  Table  I).  Anti-PCNA sera  were  rendered  monospecific by the 
following procedure. 
It was previously observed (1) that differentiated tissues such as rabbit kidney contained 
negligible amounts of PCNA but contained good concentrations of other antigens such 
as Sm and U 1-RNP (1).  Rabbit kidney extract was therefore used as a source of antigen(s) 
to absorb other antibodies from EB and PT sera as previously described (3). Rabbit kidney 
was homogenized with  a  Potter  homogenizer in  0.15  M  NaC1 (1  g  rabbit  kidney/4 ml 
0.15  M  NaCI), and the suspension was sonicated for six  15-s cycles at maximum output 
with a model W 185 sonicator (Heat System-Ultrasonics, Inc., Plainview, NY). The sonicate 
was stirred  for 4  h  at  4°C  and  centrifuged  at  3,500 g  for  20  min.  The  supernatant, 
containing ~60  mg of protein/ml,  was used as a  source for making solid-phase  immu- 
noadsorbant as described by Avrameas and Ternynck (4).  4  ml of rabbit kidney extract 
was mixed  with  4  ml  of bovine serum  albumin  (60  mg/ml),  the  latter  being used as a 
nonspecific protein  carrier.  To this  mixture,  0.8  ml of 2  M  acetate  buffer, pH  5,  was 
added, followed by 2 ml of 2.5% glutaraldehyde added dropwise. The reaction mixture 
was allowed to stand for 4 h at room temperature without stirring.  After gelation, it was 
homogenized with  a  Potter  homogenizer and  dispersed  in  50  ml  of 0.1  M  phosphate 
buffer, pH  7.4.  After centrifugation,  the  immunoadsorbant gel was washed repeatedly 
with phosphate buffer until the OD 280 nm of the supernatant  was <0.05.  The gel was 
then rehomogenized, dispersed in 50 ml of 0.2 M HCI-glycine, pH 2.8, and stirred for 15 
min  at  room  temperature.  The  gel  was  subsequently  neutralized  with  1  M  K2HPO4, 
centrifuged and dispersed in  10 ml of 0.1  M lysine, and incubated overnight at 4°C. For 
use  as  immunoadsorbant,  the  gel  was  washed  in  phosphate-buffered  saline  (PBS)  and 
resuspended  in  PBS containing 0.01%  sodium azide.  1 ml of anti-PCNA serum (EB or 
PT) was diluted  1:10 with PBS, added to 30 ml of packed gel, and incubated for 1 h at 
room temperature and for 24 h at 4°C. After this incubation, the mixture was centrifuged 
at 3,500 g for 30 min and the supernatant was recovered and concentrated to the original 
volume of anti-PCNA serum with a Minicon B 125 concentrator (Amicon Corp., Bedford, 
MA). 
Preparation  of Tissue Antigen.  Rabbit  thymus extract  (RTE)  was  used  as  the  source 
material containing PCNA. The extract was prepared as previously reported (5). For each 
90  mg of rabbit  thymus acetone powder (Pel-Freeze  Biologicals,  Rogers, AR),  1 ml of 
PBS (0.15  M NaCI, 0.01  M phosphate buffer, pH 7.4) was added. Saline-soluble antigen 
was extracted  by stirring this mixture at 4°C for 24 h. The mixture was centrifuged at 
3,000 g for 20 rain and the supernatant was used as the source of antigen, RTE. Protein 
concentration of RTE was ~ 18-21 mg/ml by the Lowry procedure (6). 
Double Immunodiffusion and Counterimmunoelectrophoresis.  The double diffusion method 
was used to demonstrate and identify the precipitin reaction between crude or purified 
antigen and specific antibodies as previously described (7). Counterimmunoelectrophoresis 
(CIE) was also used  to detect  the antigen  during its  purification  and  to determine  the 
extent of antigen purification by ascertaining the minimum amount of protein required 
to yield a  precipitin  line with  the  same antiserum.  The procedure  has been previously 
described (5). 
Rocket hnmunoelectrophoresis.  Rocket imnmnoelectrophoresis (8) was used to determine 
the amount of PCNA in preparations of crude or purified antigen. 8 ml of 1% agarose in 
0.025 M barbital buffer (50-55 °C) containing anti-PCNA serum were pipetted on to glass 
slides (5  ×  7.5 cm). After the agarose congealed, 3-mm diam wells were punched out 3 
mm  apart  and  used  as  the  cathodal  set.  20  t~l  of sample  was  added  into  each  well. 
Electrophoresis was performed in 0.05  M  barbital buffer, pH 8.4, with a current of 1.5 
mA/cm for 4 h at 4°C. After electrophoresis, the slide was incubated at room temperature 
for 24 h, washed in PBS for 2 d  with at least two changes, dried, and stained with 0.1% 
amido black  10B in  10% ethanol/1%  glacial acetic acid (Sigma Chemical Co., St.  Louis, 
MO). The heights of the rocket peaks were measured to determine the relative amount 
of PCNA in each sample. 
Antige~ Purification.  Saturated  ammonium  sulfate  solution  was prepared  by heating TAKASAKI,  FISHWILD,  AND  TAN  983 
1,000 g ammonium sulfate in ~1  liter water at 50°C until most of the salt was dissolved. 
It was allowed to stand for 3 d  at 4°C after which the pH was adjusted to 7.0  by the 
addition of NH4OH. Before fractionation with ammonium sulfate, RTE was centrifuged 
at 105,000 g for 1 h. The supernatant was used as an antigen source. To determine the 
percentage of ammonium sulfate needed to precipitate the maximum amount of PCNA 
from the crude extract, saturated ammonium sulfate solution was added dropwise to 2- 
ml aliquots of centrifuged RTE (protein concentration,  16 mg/ml). The mixtures were 
stirred  at  4°C  for 4  h,  then  centrifuged at  8,000  g  for 20  min and  the  supernatants 
discarded. Precipitates were dissolved in minimum amounts of PBS and dialyzed against 
>100 vol of the same buffer for 24 h with at least one change. After dialysis,  the volume 
was adjusted to the original volume of starting RTE. The relative amount of PCNA was 
compared by rocket immunoelectrophoresis and by titration in double immunodiffusion. 
DEAE-cellulose (DE 52 preswollen; Whatman Laboratory Products, Inc., Clifton, NJ) 
was equilibrated with 0.01  M phosphate buffer, pH 8.0, and packed in a column (1.5  × 
20 cm). A stepwise salt gradient, in which 0.1-1  M NaCI were added to starting buffer 
(0.01  M  phosphate  buffer,  pH  8.0),  was  used  for  fractionation.  PCNA  purified  by 
ammonium sulfate fraction was applied to the column and eluted with a  stepwise NaCI 
gradient in 0.1  M increments. 
Sephadex G200 (Pharmacia Fine Chemicals, Piscataway, NJ) columns of 1.5  ×  90 cm 
were used for further purification and molecular weight determinations. PBS was used as 
the running buffer. 1.5 ml of sample was applied and eluted at a flow rate of 3 ml/h. Blue 
dextran  (2,000,000  mol  wt),  human  IgG (150,000),  bovine  serum  albumin  (66,200), 
ovalbumin (45,000), and soybean trypsin inhibitor (21,500) were used as molecular weight 
markers. 
Enzyme Digestion Study and Sucrose Density Gradient Ultracentrifugation.  Partially purified 
PCNA from G200 columns was treated with deoxyribonuclease (DNase I; Millipore Corp., 
Freehold, N  J), ribonuclease (RNase A; Millipore Corp.), and trypsin (Miles Laboratories, 
Elkhart, IN). The ratio of enzyme to substrate was 1:10 by weight as previously described 
(9).  The enzyme was made up in PBS and incubated with a fivefold greater volume of 
substrate for  1 h  at 37°C.  DNase digestion was performed in PBS with 6  mM  MgCI~. 
Partially purified PCNA was sensitive to trypsin and resistant  to DNase and  RNase as 
shown  below.  The  molecular weight  of nondigested  and  enzyme-digested PCNA  was 
analyzed by sucrose density gradient ultracentrifugation. Continuous gradients were made 
with 5 and 20%  ultrapure sucrose (Schwarz Mann,  Orangeburg,  NY) in  PBS.  50 #1 of 
partially purified PCNA and enzyme-digested PCNA were mixed with 150 #1 of PBS and 
layered on top of the gradient, spun at 125,000 g for 24 h at 4°C, and collected dropwise 
from below. PCNA activity in the fractions was determined by CIE and rocket immunoe- 
lectrophoresis. 
Isoelectric Focusing.  PCNA-active fractions from G200 Sephadex columns were pooled, 
concentrated,  and  assessed  by isoelectric  focusing in  purified  agarose  (Isogel;  Marine 
Colloid Bioproducts,  Rockland,  ME).  A  1%  agarose solution  was incubated  in a  65°C 
water bath for 20 min and ampholine pH 4-6.5 (Pharmacia, Uppsala, Sweden) was added 
to final concentration of 1%. Isoelectric focusing was carried out at 600 V for 8 h at 4°C. 
The gel was stained with 0.05%  Coomassie blue in 50% methanol/10% acetic acid and 
destained. 
Preparation oflgG and Immunoprecipitation.  IgG of anti-PCNA serum (absorbed PT or 
EB) was purified by ammonium sulfate precipitation followed by DEAE-cellulose (DE 52) 
column chromatography essentially as described by Heide and Schwick (10) and Fahey 
and Terry (11).  Immunoprecipitation was performed as follows. 500 #! of IgG purified 
from absorbed EB (16.4 mg) or absorbed PT (9.2 mg/ml) was added to 50 #i of partially 
purified PCNA obtained from the G200 fraction (~120 #g protein/ml), then incubated 
for 1 h at room temperature and 72 h at 4°C. The mixture was centrifuged at 2,500 g 
for 15 min. The precipitate was washed in  PBS three times and in 0.001  M phosphate 
buffer once. After washing, the precipitates were prepared as described below for sodium 
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. 
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TABLE  I 
Characteristics of Sera Containing Antibody to PCNA 
Antibodies to: 
Serum 
PCNA  DS-DNA*  Histone  Sm  SS-A/Ro 
MN  ~  +  -  +  -  _ 
PT  +  -  -  +  + 
EB  +  -  -  +  - 
* Double-strand DNA. 
* In  MN  serum,  antibodies  to  DNA and histone  were  present  in  low 
concentration  whereas antibody to PCNA was present in high concen- 
tration. At higher dilutions of the serum, MN was operationally "mon- 
ospecific" for PCNA. 
was performed according to the method of Weber and Osborn (12)  and Laemmli (13). 
The  gels  were  formed  in  1.5  x  160  x  140  mm  slabs  that  consisted  of 7.5  or  10% 
acrylamide (wt/vol) separating gels in 0.1% SDS and Tris-HCl, pH 8.8, with 1-cm stacking 
gels containing 5% (wt/vol) acrylamide in 0.1% SDS and Tris-HCl, pH 6.8. Samples were 
dissolved in sample buffer (3% SDS, 5%  2-mercaptoethanol, 55 mM Tris-HCl, pH 6.8, 
10% glycerol, bromophenol blue) or in sample buffer without 5% 2-mercaptoethanol by 
boiling for 3 min. Samples applied to the gel were stacked at 1 mA/cm, run at 2-3 mA/ 
cm for 4-5 h, and fixed and stained with 0.04% Coomassie brilliant blue in 25% isopropyl 
alcohol/10% acetic acid overnight. 
Electrophoretic Blotting.  Partially purified PCNA was first subjected to electrophoresis 
in 10% SDS-polyacrylamide slab gel and transferred to nitrocellulose paper (NCP) accord- 
ing to the  method  of Towbin  et al.  (14).  All  manipulations were performed at room 
temperature after NCP strips (0.4 #m pore size; Millipore Corp.) were soaked in Western 
blot electrode  buffer (192  mM glycine,  25  mM  Tris base,  20%  ethanol,  pH  8.3)  and 
placed on the gel strips. The gel and NCP strips were placed between sponge pads that 
were saturated with electrode buffer. The proteins were electrophoretically transferred 
at 12 V for 3 h in electrode buffer. After electrophoresis, NCP strips were separated into 
two groups. One was stained by amido black (0.1% in 45% methanol, 10% acetic acid) to 
determine the profile of proteins transferred to the NCP strips. The other was used for 
immunological detection of PCNA. The unstained electrophoretic blots were rinsed once 
in  Western  blot  saline  (0.9%  NaCI,  10  mM  Tris-HC1,  pH  7.4,  0.025%  NP-40)  and 
incubated for  15  h  with  1%  (wt/vol) bovine serum albumin (radioimmunoassay grade; 
Sigma Chemical  Co.)  in  Western  blot saline  to saturate  additional  sites of nonspecific 
protein binding. They were rinsed in Western blot saline once and incubated with anti- 
PCNA serum (PTa,  1:100 dilution) as well as anti-Sin anti-SS-A serum (RC,  1:40) and 
normal human  serum (1:40)  for 4  h.  To remove unbound  antibody,  NCP strips were 
washed for 1 h with at least three changes of Western blot saline. Affinity-isolated goat 
anti-human IgG antibodies (Tago, Inc., Burlingame, CA) labeled with 12sI was used as the 
detecting reagent. Strips were rinsed in Western blot saline, dried for 6 h, and exposed 
to Kodak X-Omat R film at -20°C for 4 d with a Kodak hi-plus intensifying screen. 
Results 
Preparation of Specific Anti-PCNA Serum.  Our analysis demonstrated that three 
sera,  MN,  PT,  and  EB  contained  other  antibodies  in  addition  to  anti-PCNA 
(Table  I) and  absorption  studies  were performed with  the  insolubilized  immu- 
noadsorbant of rabbit kidney extract to render them "monospecific." In double 
irnmunodiffusion  analysis (Fig.  1 A),  EB  and  PT  reacted  with  RTE to produce 
two  precipitin  lines.  After  absorption  with  kidney  extract,  absorbed  sera  PT 
(PTa) and EB (EBa) showed only one precipitin line that was identical to serum TAKASAKI,  FISHWILD,  AND  TAN  985 
FIGURE  1.  Analysis of antibodies  in  sera  used  as reagents.  (.4). In  immunodiffusion,  MN 
serum reacted with RTE to give a single precipitin line that had previously been shown to be 
anti-PCNA.  However, sera EB and  PT (unabsorbed)  showed two precipitin lines, the outer 
lines fusing in immunological identity with precipitin of reference serum TT, known to contain 
anti-Sin antibody. After absorption of EB and PT sera with kidney extract (EBa and PTa), the 
Sm  antibody  was  removed  and  only  anti-PCNA  remained  in  the  absorbed  sera.  (B)  In 
counterimmunoelectrophoresis, the immunological identity of precipitins between MN serum 
and PTa and between PTa and EBa was also confirmed. Nonidentity between EBa and TT 
was demonstrated by the crossing-over of the precipitins. 
MN precipitin.  The characteristics  of the MN precipitin  line which established 
that  this  was  anti-PCNA  had  been  published  previously  (1).  The  second  line 
demonstrated by PT and EB was anti-Sm since it completely fused in immuno- 
logical identity with the reference anti-Sm serum TT.  The absorbed sera were 
also analyzed by CIE (Fig.  1B). Anti-PCNA sera MN, PTa, and EBa and anti-Sm 
sera TT were in the anodal wells; RTE (containing  PCNA) was in the cathodal 
wells. This technique, which is more sensitive than double immunodiffusion, also 
demonstrated the identity of PTa and EBa with MN and showed the absence of 
other precipitating antibodies. In a fashion characteristic of sera containing anti- 
PCNA but devoid of other types of antinuclear antibodies, EBa or PTa did not 
react with nuclei of isolated peripheral  blood lymphocytes but reacted strongly 
with the nuclei of mitogen-stimulated cells (Fig.  2).  The monospecificity of EBa 
and  PTa was further  confirmed by immunofluorescence studies on other  sub- 
strates such as mouse kidney. Before absorption, both sera showed weak staining 
of renal tubular cells, presumably due to anti-Sm and perhaps other antinuclear 
antibodies. After absorption, these sera were negative on renal tubular cells. The 
studies reported subsequently were performed primarily with PTa and EBa. Due 
to limited quantities  of MN serum that  was monospecific at serum dilutions  of 
1:160 and higher (see Table I), it was used only at certain points to confirm the 
findings. 
Purification  of PCNA.  With  RTE  as  the  starting  material,  the  first  step  of 
purification consisted of determining the optimum concentration of ammonium 
sulfate  for  its  precipitation.  By rocket  immunoelectrophoresis,  no  PCNA  was 
precipitated  below 40%  ammonium  sulfate  (Fig.  3).  Increasing  amounts  were 
obtained until  65%  saturation;  for batchwise first-step purification,  the precipi- 
tate between 40 and 65% saturation was used. This latter material  was identical 
immunologically  with  starting  RTE,  as demonstrated  in  Fig.  3B.  The  second 
step in  purification  used DEAE chromatography  with  stepwise increasing  con- 
centrations of NaCI for elution.  PCNA activity, determined by CIE and rocket 
immunoelectrophoresis  was eluted fairly discretely with  0.25  M  NaC1,  0.01  M 986  PROLIFERATING  CELL  NUCLEAR  ANTIGEN 
FIGURE 2.  (A) When EBa and PTa sera (absorbed sera to render them "monospecific" for 
PCNA) were used to stain peripheral blood lymphocytes in immunofluorescence,  no nucleolar 
staining was observed. The apparent cytoplasmic fluorescence was due to autofluorescence 
and  longer film exposure.  (B)  PHA  or concanavalin A  stimulation induced expression of 
PCNA in lymphocytes so that there was strong nuclear fluorescence after reaction with PTa 
and EBa sera. 
FIGURE 3.  Ammonium sulfate precipitation was the first step used in purification of PCNA. 
(A) Rocket immunoelectrophoresis was  used  to  measure semiquantitatively the amount of 
PCNA in precipitates. Practically all PCNA in RTE was precipitated at between 40 and 65% 
ammonium sulfate saturation. (B) The material precipitated (40-65 P) showed immunological 
identity with crude RTE and RTE clarified by centrifugation (RTE cent.). The precipitate at 
40% ammonium sulfate and the  supernate at  65%  did not contain detectable amounts of 
PCNA. 
phosphate,  pH  8.0  (Fig.  4).  This  material  was  then  dialyzed against phosphate- 
buffered  normal  saline (0.15  M  NaC1,  0.01  M  phosphate,  pH  7.4)  and  applied 
to  a  G200  column  (Fig.  5).  PCNA  activity  was  detected  over  a  wide  range  of 
elution  fractions  but  the  peak  of activity was  ~100,000  mol  wt  in reference  to TAKASAK1,  FISHWILD,  AND  TAN  987 
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FIGURE 4.  The second step in purification used DEAE column chromatography. Starting 
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FIGURE  5.  The 0.25 M  NaCI from DEAE was concentrated and analyzed on Sephadex G200 
columns.  PCNA  activity was detected  over a  wide  range of elution  fractions but the peak 
activity was in the range of 100,000 mol wt. 
the  markers  used.  Using  rocket  immunoelectrophoresis  as  a  semiquantitative 
measure of activity, the G200 material was concentrated  120-fold over starting 
RTE  (Table  II).  The  G200-derived  PCNA  retained  complete  immunological 
identity with PCNA in starting RTE as determined by double immunodiffusion. 
Properties  of Partially Purified  PCNA.  G200-derived  PCNA  activity  was  de- 
stroyed by trypsin digestion but was resistant to DNase and RNase A, strongly 988  PROLIFERATING  CELL  NUCLEAR  ANTIGEN 
TABLE  II 
Comparison of Quantitative PCNA Activities Among Crude and Partially 
Pur~ed Fractions 
Rocket im-  Protein  munoelec-  Purification  concentra- 
tion  tropho-  (-fold) 
resis* 
mg/ml 
Starting RTE  16.8  1  1 
Uhracentrifugation  15.5  0.93  1.008 
Ammonium sulfate fractionation  11.6  2.21  3.2 
DE-52 column  1.32  1.5  19 
G200 column  0.122  0.87  120 
* Ratio of height of rocket observed after various procedures compared with 
crude extract (RTE). 
t.o,  ~  .~  < 
o.9.  ~  ~  i  -~ 
0.8.  ~  ~  ~'- 
PCNA  Activity 
A  0.7  .............  +.4,++++++++  ................. 
.E 
0.6- 
"=~  0.5- 
8 
0.4- 
O  0.3- 
0.2- 
0.t- 
OI  5  10  15  2"0  2"5  30 
Bottom  Fraction Number  Top 
FIGURE 6.  Sucrose  density gradient analysis of PCNA  derived  from G200  columns.  The 
peak activity was recovered in the 94,000-100,000 tool wt range. 
suggesting that  the antigen  was  a  nuclear protein.  Its  activity was  lost  after 
incubation at 56°C for 30 min. In sucrose density gradient uhracentrifugation, 
the peak of activity was recovered in the 94,000-100,000  mol wt range (Fig. 6), 
a finding consistent with G200 filtration data.  In isoelectric focusing, the peak 
activity was at pH 4.8. 
Polypeptide Composition of  PCNA.  The G200-derived PCNA was heterogeneous 
in composition, showing at least seven polypeptide bands in polyacrylamide gel 
electrophoresis (Fig.  7, lane 5). This material was used as the antigen source in 
spontaneous immunoprecipitation with PTa and EBa sera (see Methods) and the 
immunoprecipitates were analyzed by gel electrophoresis in the presence of 2- 
mercaptoethanol. With either PTa or EBa (lane 4), a single protein of ~33,000 
mol wt was immunoprecipitated. Lanes 1 and 2 show that only heavy and light TAKASAKI,  FISHWILD,  AND  TAN  989 
FIGURE 7.  When G200-derived PCNA was analyzed in reduced polyacrylamide gels, at least 
seven protein bands were detected (lane 5). IgG alone from PTa and EBa showed the expected 
heavy and light chains (lanes 1 and 2). Immunoprecipitates of IgG and G200 material showed 
that in addition to heavy and light chains, a protein of 33,000 tool wt was present (lanes 3 and 
4). Molecular weight markers are shown in lane 6. 
chains of PTa and EBa IgG were detected when only isolated IgG were analyzed 
simultaneously. 
To confirm the above findings immunoblotting was performed with the G200- 
purified PCNA. In reduced (with 2-mercaptoethanol) or nonreduced gels several 
proteins were transferred to  nitrocellulose paper  (lanes 2  and  3,  respectively, 
Fig. 8). When parallel strips were reacted with PTa serum, only the 33,000 mol 
wt band reacted. This is illustrated in Fig. 8, lane 4 for the reduced gel transfer 
and in lane 5 for the nonreduced gel transfer. Lanes 6 and 7 show that parallel 
strips reacted with a  serum containing antibodies to Sm and SS-A/Ro, demon- 
strating the lack of reactivity of the 33,000 mol wt protein with other antinuclear 
antibodies. 
Discussion 
Our  approach  to  the  characterization  of PCNA  has  been  to  use  standard 
biochemical techniques to achieve partial purification and to use immunoprecip- 
itation and gel electrophoresis techniques to identify the antigen. The combina- 
tion of ammonium sulfate precipitation,  DEAE ion exchange chromatography 
and G200  gel filtration resulted in a  preparation of antigen that was purified 
120-fold over the original starting material from RTE. In both immunoprecipi- 
tation  and  electrotransfer immunoblotting assays,  the  reactive antigen  was  a 
33,000  mol wt polypeptide. This was consistent with the data showing that the 
reactivity of the antigen was destroyed by proteolytic treatment but was intact 
after  deoxyribonuclease  and  ribonuclease  A  treatment,  suggesting  that  the 
antigenic moiety resided in a protein component. 
Other  studies,  including  G200  gel  filtration  and  sucrose  density  gradient 990  PROLIFERATING  CELL  NUCLEAR  ANTIGEN 
FIGURE 8.  SDS-polyacrylamide gel proteins were electrophoretically transferred to nitrocel- 
lulose paper and probed  with PTa serum.  (1) molecular weight markers; (2 and 3) reduced 
and nonreduced gels blotted on nitrocellulose and stained with Coomassie; (4 and 5) reaction 
with PTa of parallel strips to 2  and 3  show reactivity with the 33,000  mol wt polypeptide. 
There was no reactivity with control sera containing anti-Sm (lane 6) and anti-SS-A/Ro (lane 
7). 
uitracentrifugation showed that the approximate molecular weight of the reactive 
antigen  was  100,000.  Although  this  appears  to  be  a  discrepancy  with  the 
immunoprecipitation  and  immunoblotting  data  that  show  the  antigen  to  be 
33,000  mol  wt recent  information  related  to the purification  of other nuclear 
autoantigens  such  as Sm and  U1-RNP (15,  16)  may help  to clarify this  issue. 
These  studies  showed  that  nuclear  antigens  exist  as  particulate  complexes  in 
association with other proteins and with nucleic acids such as small nuclear RNA. 
It is  likely that  PCNA  is also complexed with  other  proteins and  with  one or 
more species of RNA and that these complexes, under nondissociating conditions 
such as gel filtration and sucrose ultracentrifugation,  manifest molecular weights 
that are the result of protein-protein or protein-nucleic acid complexes. 
Since our initial report (1) of a nuclear antigen present in high concentration 
in  proliferating  or blast-transformed  cells,  there  have  been other  reports  that 
have some relationship to this subject. Bravo et al. (17) and Bravo and Celis (18) 
have analyzed, by two-dimensional gel electrophoresis, [35S]methionine- and [32p]_ 
orthophosphate-labeled  polypeptides  synthesized  by  spontaneously  cycling  or 
virus-transformed cells. Several nuclear polypeptides were identified whose con- 
centration  was increased as cells progressed  into  the  S phase  of the  cell cycle. 
One of these was a  36,000  moi  wt polypeptide called cyclin.  Riddle et al.  (19) 
also studied synthesis of cellular proteins in mouse 3T3 cells at different times 
during  cell  growth  and  described  certain  proteins  preferentially  stimulated 
during cell growth, one of which had a  33,000 mol wt. It is possible that one or 
both of these proteins could be related to or identical  with PCNA, and efforts 
are underway to determine this.  Barque et al. (20) have characterized a nuclear 
antigen related to the S phase of the cell cycle that is a protein of 55,000 mol wt TAKASAKI, FISHWILD,  AND  TAN  991 
and  therefore  different  from  PCNA.  Gerdes  et  al.  (21)  produced  a  mouse 
monoclonal antibody, Ki-68, to a nuclear antigen also related to the proliferative 
phase of the cell cycle. Ki-68 reacted with nuclei in tissues and cultured cell lines 
in a  manner quite similar to that  for anti-PCNA.  However, the chemical char- 
acterization of Ki-68 has not been described. 
The value of antibodies to antigens associated with blast transformation, either 
induced  by  experimental  maneuvers  or  obtained  as  spontaneously  occurring 
autoantibodies in human  diseases, lies their potential value as specific reagents. 
These  reagents  could  be  used  as  probes  to  study  processes  related  to  blast 
transformation or uncontrolled proliferation and as diagnostic markers to detect 
changes in malignant  states. In a  recent study using anti-PCNA as the reagent, 
it was possible to show that certain  peripheral  blood cells during the blast crisis 
of patients with chronic myeloid leukemia contained nuclear PCNA. 2 These cells 
were blastoid  cells but,  in  addition,  cells with  morphology of myelocytes and 
metamyelocytes contained PCNA. There was, however, a differential concentra- 
tion  of PCNA,  with  the  myelocytic cells containing  lower amounts  than  blast 
cells. This suggests that reagents such as anti-PCNA might be used to determine 
quantitatively the degree of transformation  of a cell. The potential usefulness of 
anti-PCNA for these types of studies needs to be explored further. 
Summary 
A  nuclear antigen associated with cell proliferation (proliferating cell nuclear 
antigen [PCNA]) and blast transformation is recognized by autoantibodies in the 
sera of some patients with systemic lupus erythematosus. Using this autoantibody 
as a  reagent,  PCNA was purified  120-fold by ammonium sulfate fractionation, 
DEAE chromatography,  and Sephadex G200 gel filtration.  The antigenicity of 
PCNA was sensitive to trypsin  but resistant  to ribonuclease and  deoxyribonu- 
clease,  suggesting  that  the  antigenic  determinant  resided  in  protein  and  not 
nucleic  acids.  PCNA  was  inactivated  at  56°C  for  30  min.  Isoelectrophoretic 
focusing showed that the pI was 4.8. Analysis of immunoprecipitates on polyac- 
rylamide gels showed the presence of IgG heavy and  light  chains and a  single 
polypeptide  band  of 33,000  mol  wt.  This  polypeptide band  was  the  reactive 
antigen in immunoblotting (Western transfer) assays. 
Received  for publication 5 December 1983. 
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